October 2016

Features

Tips and pearls this surgeon has amassed for the KAMRA corneal inlay, now that it’s been approved for more than a year.

Earlier this year, CMS took its first step to implement legislation modernizing how Medicare pays physicians for quality.

Consolidation has become a trend in ophthalmology. Should you be riding the wave?

This post-cataract practice is being challenged. How are surgeons responding?

Novel technologies may make it possible to detect signs of disease and begin treatment earlier than ever.

An overview of the recent updates for ICD-10, covering coding for wet and dry AMD and glaucoma.

An experienced clinician and retinal researcher discusses what the trials’ findings might mean for clinical practice.

A look at the most popular agents for chemical peels and the best ways to employ them.

It’s a potentially toxic drug that must be used with care—but when managed properly, it can help to protect vision long-term.

Early diagnosis and aggressive treatment are paramount, since these patients are often initially asymptomatic.

A look at ocular/nasal interactions and how they can affect our pharmaceutical therapies.

Experts familiar with the new Symfony IOL and the Raindrop corneal inlay share their tips for optimizing outcomes.

A 49-year-old woman presents with eye pain that’s resistant to pain medications.